Accéder au contenu
Merck

Identification of dehydroabietc acid from Boswellia thurifera resin as a positive GABAA receptor modulator.

Fitoterapia (2014-09-10)
Diana C Rueda, Melanie Raith, Maria De Mieri, Angela Schöffmann, Steffen Hering, Matthias Hamburger
RÉSUMÉ

In a two-microelectrode voltage clamp assay with Xenopus laevis oocytes, a petroleum ether extract (100 μg/mL) of the resin of Boswellia thurifera (Burseraceae) potentiated GABA-induced chloride currents (IGABA) through receptors of the subtype α₁β₂γ₂s by 319.8% ± 79.8%. With the aid of HPLC-based activity profiling, three known terpenoids, dehydroabietic acid (1), incensole (2), and AKBA (3), were identified in the active fractions of the extract. Structure elucidation was achieved by means of HR-MS and microprobe 1D/2D NMR spectroscopy. Compound 1 induced significant receptor modulation in the oocyte assay, with a maximal potentiation of IGABA of 397.5% ± 34.0%, and EC₅₀ of 8.7 μM ± 1.3 μM. This is the first report of dehydroabietic acid as a positive GABAA receptor modulator.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Streptomycin sulfate salt, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Streptomycin sulfate salt, powder
Sigma-Aldrich
Diazepam
Supelco
Diazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Streptomycin sulfate salt, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
Streptomycin, Ready Made Solution, 100 mg/mL in water
Supelco
Streptomycin solution, ~1 mg/mL in 1 mM EDTA, analytical standard
Sigma-Aldrich
Ethyl 3-aminobenzoate, 97%
Streptomycin sulfate, European Pharmacopoeia (EP) Reference Standard